Qianyuan Pharmaceutical: Qianyuan Pharmaceutical Company’s 2026 Restricted Stock Incentive Plan Self-Check Form
Shanxi Qianyuan Pharmaceutical Group Co., Ltd.
2026 Restricted Stock Incentive Plan Self-Check Form Company Abbreviation: Qianyuan Pharmaceutical Stock Code: 300254 Independent Financial Advisor: None
Does the item serial number exist? Item Remarks
(yes/no/not applicable)
Compliance requirements for listed companies
Whether the financial accounting report for the most recent fiscal year has been issued by a certified public accountant
- Audit report with negative opinion or inability to express opinion
Internal control over financial reporting for the most recent fiscal year was issued by a certified public accountant
- Audit report with negative opinion or inability to express opinion
In the past 36 months after listing, there has been any failure to comply with laws, regulations, company articles of association,
3 no
Public commitment to profit distribution
4 Are there any other circumstances that make it inappropriate to implement equity incentives? No 5 Have a performance appraisal system and methods been established? Yes 6 Are loans and any other form of financial assistance provided to incentive recipients? No
Incentive object compliance requirements
It has been stated whether shareholders include shareholders who individually or collectively hold more than 5% of the shares of a listed company.
7 or actual controllers of the incentive objects and their spouses, parents, children and foreign employees. If necessary and yes, do you explain the necessity and reasonableness of the aforementioned persons becoming the incentive objects?
Reasonableness 8 Whether independent directors are included? No 9 Whether they have been deemed inappropriate candidates by the stock exchange in the last 12 months No
Determined as inappropriate by the China Securities Regulatory Commission and its dispatched agencies within the last 12 months
10 No candidates
In the past 12 months, due to serious violations of laws and regulations, the China Securities Regulatory Commission and its dispatched
11 Whether to impose administrative penalties or take market entry ban measures
Whether you are prohibited from serving as a director or senior manager of a company as stipulated in the Company Law
12 no
Personnel situation
13 Are there any other circumstances that make it inappropriate to become an incentive target? No 14 Whether the incentive list has been verified by the Remuneration and Appraisal Committee. This is a compliance requirement for the incentive plan.
The objects involved in all equity incentive plans of listed companies within the validity period
15 No. Does the cumulative total number of shares exceed 20% of the company’s total share capital?
Huang Lequn is tired
The total number of shares granted is 16. Whether the cumulative number of shares granted to a single incentive object exceeds 1% of the company’s total share capital. Yes, the total number of shares granted exceeds 1% of the company’s total share capital.
1/5
1% of the amount
Whether the proportion of reserved equity of the incentive objects does not exceed the proposed equity incentive plan
17 is 20% of the amount of equity granted
The incentive targets are directors, senior managers, and those who individually or collectively hold more than 5% of the shares.
Shareholders or actual controllers and their spouses, parents, children and foreign employees
18 Yes, does the draft equity incentive plan list his name, position, number of awards?
quantity
19 Whether the validity period of the equity incentive plan does not exceed 10 years from the date of authorization? Yes
20 Is the draft equity incentive plan drafted by the Remuneration and Appraisal Committee? Yes
Equity Incentive Plan Disclosure Completeness Requirements
21 Are the matters stipulated in the equity incentive plan complete? Yes (1) Compare the provisions of the "Equity Incentive Management Measures" and explain whether
Listed companies are not allowed to implement equity incentives and incentive targets are not allowed to participate.
It is an equity incentive situation; explain whether the implementation of the equity incentive plan will lead to listing
The company’s equity distribution does not meet the listing conditions
(2) The purpose of the equity incentive plan, the basis and scope of determining the incentive objects Yes
(3) The number of interests to be granted by the equity incentive plan and its share in the listed company’s share capital
Proportion of the total amount; if implemented in stages, the number and proportion of rights to be granted each time
Proportion of the total share capital of a listed company; if reserved rights are set, the rights to be reserved
The number of benefits and the proportion of the total equity in the equity incentive plan; all within the validity period
Whether the cumulative total number of underlying stocks involved in the equity incentive plan exceeds
20% of the company’s total share capital and explanation of its calculation method
(4) Except for the reserved part, the incentive targets are the company’s directors and senior managers
If an employee is an employee, he shall disclose his name, position, the number of rights and interests that can be granted to each, and the proportion of the total rights and interests to be granted in the equity incentive plan; other incentive objects
(Separately or according to appropriate classification) The number of rights and interests that can be granted and the proportion of equity incentives are the total amount of rights and interests to be granted by the plan; and a single incentive object passes all
Whether the cumulative number of company shares granted under the equity incentive plan during the validity period exceeds
Explanation of exceeding 1% of the company’s total share capital
(5) Validity period, authorization date or determination of the authorization date of the equity incentive plan
Is the method, vesting date, lock-up period arrangement, etc.
(6) The grant price of restricted stocks, the exercise price of stock options and their
Determine the method. Failure to adopt Article 23 and Article 2 of the "Measures for the Administration of Equity Incentives"
If the grant price and exercise price are determined by the methods specified in Article 29, the pricing basis and pricing method shall be explained, and the independent financial adviser shall verify the pricing.
Whether it harms the interests of listed companies and small and medium-sized shareholders, express opinions and disclose
(7) Conditions for incentive objects to be granted and exercise their rights. To be awarded in installments
If the interest is granted, the conditions for the incentive objects to be granted each time shall be disclosed; it is planned to be divided into installments
When exercising rights and interests, the conditions for each exercise of rights and interests by the incentive object shall be disclosed; when rights are stipulated to be granted and the conditions for exercising rights and interests are not met, the relevant rights and interests shall not be deferred.
to the next issue; if the incentive targets include directors and senior managers, it should be disclosed
2/5
Performance evaluation indicators for incentive objects to exercise their rights and interests; disclosure of incentive objects’ exercise rights
If there are beneficial performance appraisal indicators, the scientific nature of the set indicators shall be fully disclosed.
and rationality; if the company implements multiple equity incentive plans at the same time, the later incentives
If the performance indicators of the planned company are lower than those of the previous incentive plan, the original plan should be fully explained.
Reasonableness
(8) The company's procedures for granting rights and motivating objects to exercise rights; among them,
It should be made clear that listed companies are not allowed to grant restricted stocks and that incentive targets are not allowed to exercise their rights during the period.
(9) Adjustment of the amount of equity and exercise price involved in the equity incentive plan
Methods and procedures (such as adjustment methods when implementing profit distribution, share allotment, etc. plans)
(10) Accounting treatment for equity incentives, restricted stocks or stock options
The method of determining fair value, the values of important parameters of the valuation model and their reasonableness
Yes, the implementation of equity incentives should accrue expenses and impact on the operating performance of listed companies.
influence
(11) Change and termination of equity incentive plan Yes
(12) The company’s control changes, mergers, divisions, and incentive objects occur
How to implement equity incentive plans when there are job changes, resignations, deaths, etc.
(13) The respective rights and obligations of the company and the incentive objects, and related disputes or disputes
End-to-end resolution mechanism
(14) Information disclosure documents related to equity incentive plans of listed companies do not exist
Commitments with false records, misleading statements or major omissions; incentive targets
Relevant disclosure documents contain false records, misleading statements or major omissions
If the rights granted or exercised are inconsistent with the company's commitment, all benefits will be returned to the company. Triggering of equity repurchase and cancellation and earnings recovery procedures for listed companies
Standards and timing, calculation principles of repurchase price and income, operating procedures, completion
deadline, etc.
Whether performance appraisal indicators meet relevant requirements
22 Does it include company performance indicators and individual performance indicators of incentive targets? Yes
Whether the indicators are objective, open, clear and transparent, and consistent with the actual situation of the company?
23 Is it conducive to improving the company’s competitiveness?
The selected comparison is based on relevant indicators of comparable companies in the same industry as the basis for comparison.
24 Not applicable
Whether there are no less than 3 companies
25 Do you explain the scientificity and rationality of setting the indicators? Are they compliance requirements for the restricted sale period, vesting period, and exercise period?
The period between the authorization registration date of restricted stocks (Class I) and the first release date
26 No
Whether the interval is less than 1 year
27 Is the time limit for unlocking sales in each period not less than 12 months? Yes
Whether the proportion of sales restrictions lifted in each period does not exceed the number of restricted shares granted to the incentive objects
28 is 50% of the total ticket price
Is the interval between the grant date and the first vesting date of restricted stocks (Class II)
29 Not applicable less than 1 year
3/5
30 Whether the time limit of each vesting period is not less than 12 months Not applicable
Whether the vesting ratio of each period does not exceed the total amount of restricted stocks granted to the incentive objects
31 50% not applicable
Whether the interval between the stock option grant date and the first exercisable date is less than
32 N/A 1 year
Whether the starting date of the next exercise period for stock options is not earlier than the previous exercise period
33 Not applicable
Expiration date
34 Is the exercise period of each stock option period not less than 12 months? Not applicable
Whether the proportion of stock options exercisable in each period does not exceed the incentive ratio
35 Not applicable
50% of the total amount of stock options granted
Compliance requirements for professional opinions of remuneration and appraisal committees and intermediaries
Whether the remuneration and appraisal committee discusses whether the equity incentive plan is conducive to listing
36 Express opinions on the sustainable development of the company and whether there is any obvious harm to the interests of the listed company and all shareholders.
Whether the listed company hires a law firm to issue a legal opinion and follow the
37 Issued professional opinions on the provisions of the "Equity Incentive Management Measures"
(1) Whether the listed company complies with the actual requirements stipulated in the "Equity Incentive Management Measures"
It is a condition for equity incentives
(2) Whether the content of the equity incentive plan complies with the provisions of the "Equity Incentive Management Measures"
(3) Whether the procedures for formulating, reviewing, and publicizing the equity incentive plan comply with
It is a provision of the "Measures for the Administration of Equity Incentives"
(4) Whether the determination of equity incentive objects complies with the "Equity Incentive Management Measures" and relevant laws and regulations
(5) Whether the listed company has fulfilled its credit obligations in accordance with the relevant requirements of the China Securities Regulatory Commission
Interest disclosure obligation
(6) Whether the listed company provides financial assistance to the incentive objects? No (7) Whether the equity incentive plan obviously damages the listed company and all shareholders.
Negating Dong’s interests and violating relevant laws and administrative regulations
(8) Directors who are intended to be incentive targets or directors who are related to them
Whether the inapplicable matter has been avoided in accordance with the provisions of the "Equity Incentive Management Measures"
(9) Other matters that should be explained Yes
If a listed company hires an independent financial advisor, the independent financial advisor's report shall be published
38 No
Whether the professional opinion is complete and meets the requirements of the "Equity Incentive Management Measures"
Review program compliance requirements
39 When the board of directors votes on the draft equity incentive plan, whether the related directors abstain from voting? Yes
When the shareholders’ meeting considers the draft equity incentive plan, whether the related shareholders intend to abstain from reporting
40 yes
decide
41 Are there any financial innovation matters? No
4/5
The company guarantees that the information filled in is true, accurate, complete and legal, and assumes all legal responsibilities arising from errors in the information filled in.
Board of Directors of Shanxi Qianyuan Pharmaceutical Group Co., Ltd.
August 17, 2026
5/5